MedPath

A prospective study under endoscopic treatment which examines the convenient propofol use

Phase 2
Conditions
The patient who owns the digestive diseases diagnosed as passing and the endoscopic treatment under vein general anesthesia being requirement
Registration Number
JPRN-UMIN000010547
Lead Sponsor
Juntendo university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1) The example of Informed Consent (IC) refusal.2) The direction which has merged critical liver disease, cardiac disease, a respiratory ailment, etc., and is considered that operative endoscopy is difficult.3)patient who haveallergy to eggs.4)patient who have unknown or serious allergic constitution. 4)the patient whom the doctor specializing in an exam judged to be unfit as focus of our study

Study & Design

Study Type
Interventional,observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
validity by propofol use by this medication method
Secondary Outcome Measures
NameTimeMethod
evaluation of dose by the background factor difference of patient with the use of propofol
© Copyright 2025. All Rights Reserved by MedPath